AstraZeneca has penned a drug discovery pact focused on chronic diseases with China's CSPC Pharma. The FDA has halted new trials that export U.S. individuals' living cells to China. | AstraZeneca has ...

Currently, Alphamab trades at a price-to-earnings (P/E) ratio of 44 times, even higher than the 30 times for Henlius Biotech ...

AstraZeneca signed a potential $5 billion research deal with Chinese drugmaker CSPC. Eli Lilly is buying Verve Therapeutics for $1 billion upfront plus a CVR potentially worth another $300 million.

The Missouri Union Presbytery held their meeting at Coates Street Presbyterian Church in Moberly, with approximately 65 ...

A defective lithium-ion battery in a different Anker device has been linked to reports of fires and explosions. Here's how to ...

US chemical output slows, National Resilience consolidates operations, AstraZeneca partners with a Chinese firm, and more ...

Corbus Pharmaceuticals Holdings' financial position is stable for now, with about two years of cash runway. Click here to ...

Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...

CSPC Pharmaceutical Group Ltd. announced June 13 that it struck a potential $5.33 billion deal with Astrazeneca plc to ...

Asia-Pacific markets delivered a mixed performance on Tuesday as investors weighed the implications of escalating tensions in ...

Hot Stocks}SANDS CHINA LTD quoted at HK$15.66, up 5.2% 17/06/2025 10:18 {Hot Stocks}SINO BIOPHARM quoted at HK$5.13, down 2.8% 17/06/2025 10:11 {Hot Stocks}CSPC PHARMA(01093) quoted at HK$8.49, down 3 ...